Article info
PDFInterventional cardiology
Original article
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention
- Correspondence to Jurrien M ten Berg, Department of Cardiology, St Antonius Hospital, P O Box 2500, 3435 CM Nieuwegein, The Netherlands; j.ten.berg{at}antoniusziekenhuis.nl
Citation
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention
Publication history
- Accepted February 22, 2011
- First published April 8, 2011.
Online issue publication
May 16, 2011
Article Versions
- Previous version (8 April 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.